Reaction

Epicondylitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,488 reports · 20 co-occurring drugs

As of the last recalculation, Epicondylitis appears in 1,488 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is PHYTONADIONE (PRR 19.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Phytonadione1219.920.0
Ciprofolxacin9419.519.6
Ciprofloxacin Tablets9419.519.6
Ciprofloxacin11418.718.8
Hydroxychloroquine Sulfate11218.518.5
Ciprofloxacin Hydrochloride11517.817.9
Calcium, Magnesium, Potassium, And Sodium Oxybates1016.316.4
Ciprofloxacin Hydrochloride And Hydrocortisone2114.314.3
Indapamide1814.214.2
Celecoxib8910.010.0
Rizatriptan Benzoate79.79.7
Sulfasalazine499.09.0
Loratadine And Pseudoephedrine Sulfate58.88.8
Anakinra108.58.5
Naltrexone Hydrochloride And Bupropion Hydrochloride58.28.2
Certolizumab Pegol546.76.7
Abatacept586.16.1
Armodafinil96.06.0
Conjugated Estrogens And Medroxyprogesterone Acetate84.84.8
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate43.13.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.